Les Barons de la Bourse

Lori Friedman

Age : 57

Patrimoine public : 295 500 USD

Principales sociétés :

ORIC Pharmaceuticals, Inc. -

Jiya Acquisition Corp.

Synthèse

Presently, Lori Friedman is Chief Scientific Officer for Oric Pharmaceuticals, Inc.

She is also on the board of Project Scientist and Jiya Acquisition Corp.

In the past Dr. Friedman was Head-Translational Oncology at Genentech, Inc.

She received a doctorate from the University of California, Berkeley.

Postes et responsabilités de Lori Friedman

Nom	Titre	Depuis
ORIC Pharmaceuticals, Inc. (Recherche biotechnologique et médicale)	Chief Scientific Officer	2019
Jiya Acquisition Corp. (Sociétés holdings)	Independent Director	2021
Project Scientist	Director	-

Participations de Lori Friedman

Nom	Actions	%	Valorisation
Jiya Acquisition Corp.	30 000	1,00%	295 500 USD

Lori Friedman: Réseau personnel

Nom	Sociétés liées
Mayank Gandhi	Jiya Acquisition Corp.
Richard D. van Doren	Jiya Acquisition Corp.
Pamela M. Klein	Jiya Acquisition Corp.
Stephen M. Kelsey	Jiya Acquisition Corp.
Cory S. Freedland	Jiya Acquisition Corp.
Srinivas Akkaraju	Jiya Acquisition Corp.
Rekha Hemrajani	Jiya Acquisition Corp.
Daniel K. Spiegelman	Jiya Acquisition Corp.
Jacob M. Chacko	ORIC Pharmaceuticals, Inc.
Steven L. Hoerter	ORIC Pharmaceuticals, Inc.